Old Web
English
Sign In
Acemap
>
authorDetail
>
Gail J. Roboz
Gail J. Roboz
Johns Hopkins University
Pharmacokinetics
Medicine
Refractory
Immunology
Topoisomerase
3
Papers
36
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase Ib/II pharmacokinetic/pharmacodynamic (PK/PD) study of combination voreloxin and cytarabine in relapsed or refractory AML patients
2009
Journal of Clinical Oncology
Jeffrey E. Lancet
Jeffrey M. Karp
Larry D. Cripe
Gail J. Roboz
M. Wollman
C. Berman
Andrew Conroy
R Hawtin
Judith A. Fox
Glenn Michelson
Show All
Source
Cite
Save
Citations (3)
Voreloxin (formerly known as SNS-595) in Combination with Cytarabine Demonstrates Preliminary Clinical Responses in a Phase 1 Study in Relapsed/Refractory Acute Myeloid Leukemia.
2008
Blood
Jeffrey Lancet
Judith E. Karp
Larry D. Cripe
Gail J. Roboz
Matt Suster
Nguyen Tan
Rachael Hawtin
Judith Fox
C. Berman
Glenn Michelson
Show All
Source
Cite
Save
Citations (3)
A Phase I Dose Escalation Study of KW-2449, An Oral Multi-Kinase Inhibitor against FLT3, Abl, FGFR1 and Aurora in Patients with Relapsed/Refractory AML, ALL and MDS or Resistant/Intolerant CML
2008
Blood
Jorge Cortes
Gail J. Roboz
Hagop M. Kantarjian
Eric J. Feldman
Judith E. Karp
Keith W. Pratz
Niranjan S. Rao
Shiro Akinaga
Mark J. Levis
Show All
Source
Cite
Save
Citations (30)
1